drugset / Trial / NCT01133613
Double-Blind, Randomized, Single Dose Escalation Safety Study of Intraarticular Bone Morphogenic Protein (38A BMP-7) in Subjects With Osteoarthritis (OA) of the Knee
RandomizedSingle-groupQuadruple-blindTreatment
Summary
The objective of the study is to determine the safety and tolerability of two different formulations of BMP-7 for the treatment of osteoarthritis of the knee.
Timeline
- Start
- 2010-05
- Primary completion
- 2011-10
- Completion
- 2011-10
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Bone morphogenetic protein 7 | Unknown | 0.03 mg/ml | Other |
| Subject | Bone morphogenetic protein 7 | Unknown | 0.1 mg/ml | Other |
| Subject | Bone morphogenetic protein 7 | Unknown | 0.3 mg/ml | Other |